103 related articles for article (PubMed ID: 124742)
21. Enhancement by hemin of the sensitivity of K562 human leukemic cells to 1-beta-D-arabinofuranosylcytosine.
Okabe-Kado J; Hayashi M; Honma Y; Hozumi M
Cancer Res; 1986 Mar; 46(3):1239-43. PubMed ID: 3455882
[TBL] [Abstract][Full Text] [Related]
22. MCL-1, a member of the BLC-2 family, is induced rapidly in response to signals for cell differentiation or death, but not to signals for cell proliferation.
Yang T; Buchan HL; Townsend KJ; Craig RW
J Cell Physiol; 1996 Mar; 166(3):523-36. PubMed ID: 8600156
[TBL] [Abstract][Full Text] [Related]
23. Secondary activities of diverse inhibitors potentiate the response of hamster embryo cultures to a mitotic stimulus.
Mironescu S; Ellem KA
J Cell Physiol; 1977 Feb; 90(2):281-93. PubMed ID: 557049
[TBL] [Abstract][Full Text] [Related]
24. 1,25-Dihydroxycholecalciferol-induced differentiation of myelomonocytic leukemic cells unresponsive to colony stimulating factors and phorbol esters.
Bettens F; Schlick E; Farrar W; Ruscetti F
J Cell Physiol; 1986 Dec; 129(3):295-302. PubMed ID: 3491083
[TBL] [Abstract][Full Text] [Related]
25. Differentiation of thymocytes: evidence that induction of the surface phenotype requires transcription and translation.
Storrie B; Goldstein G; Boyse EA; Hammerling U
J Immunol; 1976 May; 116(5):1358-62. PubMed ID: 1083871
[TBL] [Abstract][Full Text] [Related]
26. Terminal differentiation of the human promyelocytic leukemia cell line, HL-60, in the absence of cell proliferation.
Ferrero D; Tarella C; Gallo E; Ruscetti FW; Breitman TR
Cancer Res; 1982 Nov; 42(11):4421-6. PubMed ID: 6957259
[TBL] [Abstract][Full Text] [Related]
27. IL-6 is a differentiation factor for M1 and WEHI-3B myeloid leukemic cells.
Chiu CP; Lee F
J Immunol; 1989 Mar; 142(6):1909-15. PubMed ID: 2784140
[TBL] [Abstract][Full Text] [Related]
28. Prolonged exposure to cytosine arabinoside in the presence of hematopoietic growth factors preferentially kills leukemic versus normal clonogenic cells.
Van Der Lely N; De Witte T; Muus P; Raymakers R; Preijers F; Haanen C
Exp Hematol; 1991 May; 19(4):267-72. PubMed ID: 2055291
[TBL] [Abstract][Full Text] [Related]
29. Growth inhibition and augmentation of mouse myeloid leukemic cell line differentiation by interleukin 1.
Onozaki K; Tamatani T; Hashimoto T; Matsushima K
Cancer Res; 1987 May; 47(9):2397-402. PubMed ID: 3494508
[TBL] [Abstract][Full Text] [Related]
30. Effects of thymidine analogs upon growth control in cultured hormone-dependent ray ovary cells.
Mathews CK
Exp Cell Res; 1975 Apr; 92(1):39-46. PubMed ID: 124255
[No Abstract] [Full Text] [Related]
31. Macromolecular and cell cycle effects of different classes of agents inducing the maturation of human myeloblastic leukemia (ML-1) cells.
Craig RW; Frankfurt OS; Sakagami H; Takeda K; Bloch A
Cancer Res; 1984 Jun; 44(6):2421-9. PubMed ID: 6586286
[TBL] [Abstract][Full Text] [Related]
32. Mechanism of interaction between interferon-gamma and antineoplastic agent on the differentiation of HL-60 promyelocytic cells.
Kafka M; Dvilansky A; Nathan I
Exp Hematol; 1990 Mar; 18(3):153-8. PubMed ID: 2105896
[TBL] [Abstract][Full Text] [Related]
33. Growth inhibition by thymidine of leukemic HL-60 and normal human myeloid progenitor cells.
Akman SA; Ross DD; Rosen H; Salinger C; Andrews PA; Chou FE; Bachur NR
Cancer Res; 1981 Jun; 41(6):2141-6. PubMed ID: 6940654
[TBL] [Abstract][Full Text] [Related]
34. Proto-oncogene expression and dissection of the myeloid growth to differentiation developmental cascade.
Liebermann DA; Hoffman-Liebermann B
Oncogene; 1989 May; 4(5):583-92. PubMed ID: 2471131
[TBL] [Abstract][Full Text] [Related]
35. Regulation of growth and differentiation by phorbol esters and the mechanism of tumor promotion.
Lotem J; Sachs L
Carcinog Compr Surv; 1982; 7():385-90. PubMed ID: 6978180
[TBL] [Abstract][Full Text] [Related]
36. A factor in human saliva that induces differentiation of mouse myeloid leukemia cells.
Nakayasu M; Shimamura S; Takeuchi T; Sato S; Sugimura T
Cancer Res; 1978 Jan; 38(1):103-9. PubMed ID: 271041
[TBL] [Abstract][Full Text] [Related]
37. 5-bromodeoxyuridine-induced differentiation of a neuroblastoma.
Schubert D; Jacob F
Proc Natl Acad Sci U S A; 1970 Sep; 67(1):247-54. PubMed ID: 5272316
[TBL] [Abstract][Full Text] [Related]
38. Induction of proliferation and NK activity in human lymphocytes by mature myelomonocytic cells: evidence for an HLA-DR-independent MLR stimulatory ability of terminally differentiated nonlymphoid leukemic cell lines and of normal peripheral blood granulocytes.
Santoli D; Francis MK; Matera L; Ferrero D
J Immunol; 1983 Aug; 131(2):736-42. PubMed ID: 6306106
[TBL] [Abstract][Full Text] [Related]
39. Induction of specific changes in the surface membrane of myeloid leukemic cells by steroid hormones.
Lotem J; Sachs L
Int J Cancer; 1975 May; 15(5):731-40. PubMed ID: 1079793
[TBL] [Abstract][Full Text] [Related]
40. Studies of the mechanism of induction of infectious murine leukemia virus from AKR mouse embryo cell lines by 5-iododeoxyuridine and 5-bromodeoxyuridine.
Teich N; Lowy DR; Hartley JW; Rowe WP
Virology; 1973 Jan; 51(1):163-73. PubMed ID: 4346294
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
